CLASS II Device recall · Reported 19 Aug 2020 · FDA Enforcement Report

Vitros Anti-Sars-CoV-2 Total Reagent, COV2TOT, Vitros CoV2T recalled

Ortho Clinical Diagnostics is recalling Vitros Anti-Sars-CoV-2 Total Reagent, COV2TOT, Vitros CoV2T, distributed nationwide in the US. The recall was initiated on 17 Jul 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots 0010-0037
Quantity recalled47,271 sales units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2770-2020
FDA event ID
86038
Recalling firm
Ortho Clinical Diagnostics, Rochester, NY
Classification
Class II
Status
Terminated
Recall initiated
17 Jul 2020
FDA classified
7 Aug 2020
Reported
19 Aug 2020
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Device Malfunction

Timeline

17 Jul 2020Recall initiated by company
7 Aug 2020Classified by FDA+21 days
19 Aug 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The reagent bottles may be swapped within the reagent pack, which may lead to false negative results or delayed results due to calibration failures, or quality control failures.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

VITROS Anti-SARS-CoV-2 Total Reagent, COV2TOT, VITROS CoV2T. Catalog number 6199922, UDI 10758750033386 - Product Usage: Rx ONLY. For in vitro diagnostic and Laboratory Professional use. For emergency authorization use only.

Where it was distributed

Worldwide distribution - US Nationwide distribution.

Nationwide

Questions about this recall

Why was it recalled?

The reagent bottles may be swapped within the reagent pack, which may lead to false negative results or delayed results due to calibration failures, or quality control failures.

Which lots are affected?

Lots 0010-0037

Where was it sold?

Worldwide distribution - US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 86038

This product is part of a recall event; the main page for the event is Vitros Anti-Sars-CoV-2 IgG Reagent Pack, COV2IgG, Vitros CoV2G recalled.

More recalls from Ortho Clinical Diagnostics

All 311

Other Test Kits & Diagnostics recalls

All 2,656